Fermion announces IND Approval of Non-Addictive Pain Relief Drug FZ008-145 by China NMPA
(Adnkronos) – GUANGZHOU, China, Jan. 10, 2024 /PRNewswire/ — Guangzhou Fermion Technology Co., Ltd. (Fermion), a clinical-stage AI-based drug discovery company that specializes in developing drugs for autoimmune diseases and pain, has
